Multi-omics-constrained kinetic models quantify pathway rewiring and predict metabolic vulnerabilities in BRCA1-deficient ovarian cancer
Cell Systems · 2026-11 · 101781
DOI: 10.1016/j.cels.2026.101781 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Systems, 2026-11. Verfasst von Ilias Toumpe und 3 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Computational Systems Biotechnology, École Polytechnique Fédérale de Lausanne (EPFL), 1015 Lausanne, Switzerland. Die Arbeit nennt 123 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swiss National Science Foundation, Horizon Europe, Swiss Federal Institute of Technology Lausanne.
Abstract (Originalsprache)
Time-resolved, network-wide consequences of cancer metabolic reprogramming remain poorly understood. We built multi-omics-constrained, near-genome-scale kinetic ensembles for isogenic BRCA1 wild-type and BRCA1-mutant ovarian cancer cells. Covering over 2,100 reactions, the ensembles enabled uncertainty-quantified simulations of nutrient, metabolite, and enzyme perturbations. Metabolic control analysis identified 28 enzyme-mediated vulnerabilities; 24 are linked to experimental or approved DrugBank compounds, whereas four lack documented drug associations. Independent DepMap data supported a subset of these candidates. All 28 emerged directly from the mechanistic model structure and multi-omics constraints, with no calibration to known drug targets or cancer-dependency data. Simulations of thymidylate synthase, hexokinase, and triokinase inhibition predicted target- and physiology-specific changes in pathway use, energy metabolism, and a shared ceramide-linked stress response. Mapping predicted enzyme-activity shifts to BRCA1-associated transcription factors suggested regulatory routes underlying differences between the two states. These ensembles provide a reusable framework for time-resolved, mechanistic hypothesis generation across cancers and other diseases. A record of this paper's transparent peer review process is included in the supplemental information.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratory of Computational Systems Biotechnology, École Polytechnique Fédérale de Lausanne (EPFL), 1015 Lausanne, Switzerland.
- Ludwig Institute for Cancer Research, Department of Oncology, University of Lausanne, Lausanne University Hospital (CHUV), 1011 Lausanne, Switzerland. Electronic address: maria.masidbarcon@unil.ch.
- Laboratory of Computational Systems Biotechnology, École Polytechnique Fédérale de Lausanne (EPFL), 1015 Lausanne, Switzerland. Electronic address: vassily.hatzimanikatis@epfl.ch.
- Laboratory of Computational Systems Biotechnology, École Polytechnique Fédérale de Lausanne (EPFL), 1015 Lausanne, Switzerland; AI center, EPFL, 1015 Lausanne, Switzerland. Electronic address: ljubisa.miskovic@epfl.ch.
Förderung
- Swiss National Science Foundation
- Horizon Europe
- Swiss Federal Institute of Technology Lausanne
Zitieren
APA
Toumpe, I., Masid, M., Hatzimanikatis, V., & Miskovic, L. (2026). Multi-omics-constrained kinetic models quantify pathway rewiring and predict metabolic vulnerabilities in BRCA1-deficient ovarian cancer. Cell Systems, 101781. https://doi.org/10.1016/j.cels.2026.101781
Vancouver
Toumpe I, Masid M, Hatzimanikatis V, Miskovic L. Multi-omics-constrained kinetic models quantify pathway rewiring and predict metabolic vulnerabilities in BRCA1-deficient ovarian cancer. Cell Systems. 2026:101781. doi:10.1016/j.cels.2026.101781
BibTeX
@article{Toumpe2026,
author = {Toumpe, Ilias and Masid, Maria and Hatzimanikatis, Vassily and Miskovic, Ljubisa},
title = {Multi-omics-constrained kinetic models quantify pathway rewiring and predict metabolic vulnerabilities in BRCA1-deficient ovarian cancer},
journal = {Cell Systems},
year = {2026},
pages = {101781},
doi = {10.1016/j.cels.2026.101781}
}
EUVIMED